Explore 3 Stock Ideas & Industry Insights Download Free Report
• Separate trading of shares and warrants begins on or about July 6, 2026.
• Cumberland Pharmaceuticals Inc. Has closed a $100 million transaction with Apotex for FDA-approved products.
• CareView Communications has successfully amended its Credit Agreement, extending the maturity date.
• Pre‑funded warrants covering up to 960,000 common shares were sold at a combined price of $3.1249 per unit.
• Sprinklr (NYSE: CXM) disclosed on July 1, 2026 that Thomas Addis will assume the role of Chief Revenue Officer.
• Evergy Kansas Central issued $350 million in first mortgage bonds carrying a 5.3% coupon, maturing in 2036.
• The company will use the net proceeds of $565K to further develop its N-trans-caffeoyltyramine business and products.
• First BanCorp appoints a new Executive Vice President and CFO with an annual base salary of $475,000.
• Payment to preferred shareholders is scheduled for July 30, 2026.
• CNS Pharmaceuticals (NASDAQ: CNSP) disclosed a $22.5M private investment in public equity (PIPE) to advance its strategic initiatives.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…